| __timestamp | Apellis Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 19586000 |
| Thursday, January 1, 2015 | 13730311 | 29135000 |
| Friday, January 1, 2016 | 22978599 | 42791000 |
| Sunday, January 1, 2017 | 40303878 | 49577000 |
| Monday, January 1, 2018 | 105285576 | 89209000 |
| Tuesday, January 1, 2019 | 220968770 | 69099000 |
| Wednesday, January 1, 2020 | 299921000 | 75961000 |
| Friday, January 1, 2021 | 420869000 | 90467000 |
| Saturday, January 1, 2022 | 387236000 | 74552000 |
| Sunday, January 1, 2023 | 354387000 | 91593000 |
Data in motion
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Apellis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
Since 2014, Apellis has shown a remarkable upward trajectory in its R&D spending, peaking in 2021 with a staggering 420% increase from its 2014 levels. This aggressive investment underscores Apellis's commitment to pioneering new treatments and therapies.
Conversely, Supernus has maintained a more steady approach, with its R&D expenses growing by approximately 370% over the same period. This consistent investment reflects a balanced strategy, focusing on sustainable growth and innovation.
As we look to the future, these trends highlight the diverse approaches companies take in the race for pharmaceutical breakthroughs.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.